Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
What is the effect of framing of outcomes of medicinal treatment for hypertension on decisions about whether to take medication?
ISRCTN ISRCTN33771631
ClinicalTrials.gov identifier
Public title What is the effect of framing of outcomes of medicinal treatment for hypertension on decisions about whether to take medication?
Scientific title
Acronym HIPPO (Health Information Project, Presentation Online)
Serial number at source N/A
Study hypothesis Our two main comparisons were formulated as the following null-hypotheses:
1. The congruence between participants’ values and their treatment decision is not better for positively framed messages showing gain over 10 years than for negatively framed messages showing loss over 10 years.
2. The congruence between participants’ values and their treatment decision is not better for negatively framed messages showing loss over 10 years than for negatively framed messages showing loss per year over 10 years.
Lay summary
Ethics approval The University at Buffalo (New York, USA), Health Sciences Institutional Review Board, approved on 15 May 2002.
Study design Randomized controlled trial
Countries of recruitment Norway
Disease/condition/study domain Hypertension (hypothetical scenario)
Participants - inclusion criteria At least 18 years of age and fluent in Norwegian.
Participants - exclusion criteria Previous participation in this trial.
Anticipated start date 01/11/2004
Anticipated end date 31/05/2005
Status of trial Completed
Patient information material
Target number of participants 2400
Interventions Presentation of three statements about the effects of antihypertensives in preventing coronary vascular disease over ten years that are framed differently.
Primary outcome measure(s) Hypothetical treatment decision: to take or not to take antihypertensives.
Secondary outcome measure(s) No secondary outcome measures
Sources of funding Norwegian research council (Norway)
Trial website
Publications 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20209127
Contact name Ms  Cheryl  Carling
  Address PO box 7004
St Olavs Plass
  City/town Oslo
  Zip/Postcode N-0130
  Country Norway
  Tel +47 98627327
  Email cheryl.carling@kunnskapssenteret.no
Sponsor Norwegian Knowledge Centre for the Health Services (Norway)
  Address PO box 7004
St Olavs Plass
  City/town Oslo
  Zip/Postcode N-0130
  Country Norway
  Tel +47 23 25 50 00
  Fax +47 23 25 50 10
  Email post@kunnskapssenteret.no
  Sponsor website: http://www.kunnskapssenteret.no/
Date applied 09/03/2007
Last edited 09/03/2010
Date ISRCTN assigned 04/05/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central